These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28268248)

  • 1. Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
    Keum N; Yuan C; Nishihara R; Zoltick E; Hamada T; Martinez Fernandez A; Zhang X; Hanyuda A; Liu L; Kosumi K; Nowak JA; Jhun I; Soong TR; Morikawa T; Tabung FK; Qian ZR; Fuchs CS; Meyerhardt JA; Chan AT; Ng K; Ogino S; Giovannucci EL; Wu K
    Int J Cancer; 2017 Jun; 140(12):2648-2656. PubMed ID: 28268248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.
    Hanyuda A; Kim SA; Martinez-Fernandez A; Qian ZR; Yamauchi M; Nishihara R; Morikawa T; Liao X; Inamura K; Mima K; Cao Y; Zhang X; Wu K; Chan AT; Giovannucci EL; Meyerhardt JA; Fuchs CS; Shivdasani RA; Ogino S
    Ann Surg Oncol; 2016 Mar; 23(3):908-17. PubMed ID: 26577117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.
    Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary glycemic index and glycemic load and risk of colorectal cancer: results from the EPIC-Italy study.
    Sieri S; Krogh V; Agnoli C; Ricceri F; Palli D; Masala G; Panico S; Mattiello A; Tumino R; Giurdanella MC; Brighenti F; Scazzina F; Vineis P; Sacerdote C
    Int J Cancer; 2015 Jun; 136(12):2923-31. PubMed ID: 25403784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
    Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
    Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
    Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dietary insulin scores on survival in colorectal cancer patients.
    Yuan C; Bao Y; Sato K; Nimptsch K; Song M; Brand-Miller JC; Morales-Oyarvide V; Zoltick ES; Keum N; Wolpin BM; Meyerhardt JA; Chan AT; Willett WC; Stampfer MJ; Wu K; Giovannucci EL; Fuchs CS; Ng K
    Br J Cancer; 2017 Sep; 117(7):1079-1087. PubMed ID: 28817837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.
    Mei ZB; Duan CY; Li CB; Cui L; Ogino S
    Ann Oncol; 2016 Oct; 27(10):1836-48. PubMed ID: 27436848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
    Morikawa T; Kuchiba A; Yamauchi M; Meyerhardt JA; Shima K; Nosho K; Chan AT; Giovannucci E; Fuchs CS; Ogino S
    JAMA; 2011 Apr; 305(16):1685-94. PubMed ID: 21521850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women.
    Michaud DS; Fuchs CS; Liu S; Willett WC; Colditz GA; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):138-47. PubMed ID: 15668487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
    Hua X; Phipps AI; Burnett-Hartman AN; Adams SV; Hardikar S; Cohen SA; Kocarnik JM; Ahnen DJ; Lindor NM; Baron JA; Newcomb PA
    J Clin Oncol; 2017 Aug; 35(24):2806-2813. PubMed ID: 28617623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer.
    Loree JM; Bailey AM; Johnson AM; Yu Y; Wu W; Bristow CA; Davis JS; Shaw KR; Broaddus R; Banks KC; Lanman RB; Meric-Bernstam F; Overman MJ; Kopetz S; Raghav K
    J Natl Cancer Inst; 2018 Dec; 110(12):1409-1417. PubMed ID: 29718453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
    Xu K; Wang J; Gao J; Di J; Jiang B; Chen L; Wang Z; Wang A; Wu F; Wu W; Shen L; Su X
    Oncol Rep; 2016 Sep; 36(3):1672-8. PubMed ID: 27460045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
    Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort study of fatty acid synthase expression and patient survival in colon cancer.
    Ogino S; Nosho K; Meyerhardt JA; Kirkner GJ; Chan AT; Kawasaki T; Giovannucci EL; Loda M; Fuchs CS
    J Clin Oncol; 2008 Dec; 26(35):5713-20. PubMed ID: 18955444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic index, glycemic load, and pancreatic cancer risk (Canada).
    Silvera SA; Rohan TE; Jain M; Terry PD; Howe GR; Miller AB
    Cancer Causes Control; 2005 May; 16(4):431-6. PubMed ID: 15953985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
    Nakayama I; Shinozaki E; Matsushima T; Wakatsuki T; Ogura M; Ichimura T; Ozaka M; Takahari D; Suenaga M; Chin K; Mizunuma N; Yamaguchi K
    BMC Cancer; 2017 Jan; 17(1):38. PubMed ID: 28068936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.